Usage: hypolipidemic drug. It is used to treat hypercholesterolemia and familial hypercholesterolemia.
Properties
Summary
Pitavastatin calcium is the first fully synthesized HMG CoA reductase inhibitor jointly developed by Nissan Chemical and Xinghe Co., Ltd. It belongs to statins. It mainly reduces the ability of liver to produce cholesterol by inhibiting a liver enzyme called hmgco-a reductase, so as to improve the elevated blood cholesterol level, It is mainly used to treat patients with hypercholesterolemia and familial hypercholesterolemia. Its lipid-lowering effect is very good, and it is the most effective lipid-lowering drug so far.